Bullet 1 revised: "...However, breast reconstruction should not interfere with the appropriate surgical, medical, and radiationmanagement of the cancer or the scope of appropriate surgical treatment for this disease...The availability of or the practicality of...
Guidelines Update Methodology 在更新该版NCCN乳腺癌指南之前,采用以下检索词进行电子检索获取乳腺癌关键文献:乳腺癌、乳腺肿瘤、导管原位癌、炎性乳腺癌、或叶状乳腺癌。 Prior to the updateof this version of the NCCN Guidelines for Breast Cancer, an electronic search of the PubMed database was performed t...
medical, and radiationmanagement of the cancer or the scope of appropriate surgical treatment for this disease...The availability of or the practicality of breast reconstruction should not result in the delay or refusal of appropriate surgical, medical, and radiationintervention." ...
Bullet 1 revised: "...However, breast reconstruction should not interfere with the appropriate surgical, medical, and radiationmanagement of the cancer or the scope of appropriate surgical treatment for this disease...The availability of or the practicality of breast reconstruction should not result i...
Guidelines Update Methodology 在更新该版NCCN乳腺癌指南之前,采用以下检索词进行电子检索获取乳腺癌关键文献:乳腺癌、乳腺肿瘤、导管原位癌、炎性乳腺癌、或叶状乳腺癌。 Prior to the update of this version of the NCCN Guidelines for Breast Cancer, an electronic search of the PubMed database was performed...
Imaging, 3rd bullet added:For patients with germline mutations or family history of breast cancer, please refer to See NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic 新增:治疗后监测 Added:Post treatment monitoring ...
NCCN Updates Guidelines on Breast Cancer TreatmentChristin Melton
[5]Primary results from TROPiCS-02: A randomized phase 3 study of sacituzumab govitecan (SG) versus treatment of physician’s choice (TPC) in patients (Pts) with hormone receptor–positive/HER2-negative (HR+/HER2-) advanced breast cancer. | Journal of Clinical Oncology ...
All Rights Reserved. NCCN Guidelines Version 4.2022 NCCN Guidelines Index Table of Contents Breast Cancer Discussion *William J. Gradishar, MD/Chair ‡ † Sharon H. Giordano, MD, MPH † Lori J. Pierce, MD § Robert H. Lurie Comprehensive Cancer The University of Texas University of Michi...
Systemic therapy is based on the stage and biological characteristics of any underlying cancer, and is supported by the evidence cited in the relevant stage-specific breast cancer treatment guidelines. 全身治疗是根据任何潜在癌症的分期和生物学特征,并被相关的特定分期乳腺癌治疗指南所引用的证据支持。